外周血单个核细胞黑色素瘤缺乏因子2在原发性肝癌中的表达及其临床意义

新发传染病电子杂志 ›› 2019, Vol. 4 ›› Issue (3): 149-151.

外周血单个核细胞黑色素瘤缺乏因子2在原发性肝癌中的表达及其临床意义

陈洪涛, 杨智, 吴诗品

暨南大学第二临床医学院/深圳市人民医院, 广东深圳 518020

出版日期:2019-09-30 发布日期:2020-07-21
通讯作者: 吴诗品, Email:wupoem@126.com

Expression of absent in melanoma 2 mRNA in peripheral blood mononuclears and its significance in primary hepatocellular carcinoma

CHEN Hong-tao, Yang Zhi, WU Shi-pin

Shenzhen People’s Hospital, Jinan University, Guang dong Shenzhen 518020, China

Online:2019-09-30 Published:2020-07-21

摘要/Abstract

摘要： 目的探讨外周血单个核细胞黑色素瘤缺乏因子2（AIM2）在原发性肝癌（HCC）患者中的表达及其临床意义。方法通过逆转录PCR和实时荧光定量PCR检测41例HCC患者外周血单个核细胞AIM2 mRNA的表达水平, 分析其与患者肝内肿瘤直径、肝外转移和肝功能储备评分的相互关系。结果肝内瘤体直径小于5cm的患者较肝内瘤体直径大于5cm的患者具有更高的AIM2 mRNA表达水平（P=0.006）, 未发生肝外转移者较肝外转移者有更高的AIM2 mRNA表达水平（P=0.025）, 肝功能储备A级和B级的患者较C级患者有更高的AIM2 mRNA表达水平（P<0.0001）。结论外周血单个核细胞AIM2 mRNA的表达水平与HCC病情进展呈负相关, AIM2可能是HCC病情评估的潜在生物标志物和治疗干预的潜在靶点。

关键词: 黑色素瘤缺乏因子2, 原发性肝癌, 外周血单个核细胞

Abstract: Objective To analyze the expression level of absent in melanoma 2(AIM2) in peripheral blood mononuclears(PBMCs) and its significance in primary hepatocellular carcinoma(HCC). Methods The mRNA expression levels of AIM2 in PBMCs in 41 patients with HCC were detected by reverse transcription PCR and real-time fluorescence quantitative PCR, and the relationship between the liver tumor diameters, extrahepatic metastasis and liver function reserve scores were analyzed. Results Patients with the diameter of the intrahepatic tumor less than 5cm had higher AIM2 mRNA expression levels than those with the diameter of the intrahepatic tumor greater than 5cm (P = 0.006). The AIM2 mRNA expression levels were higher in patients without extrahepatic metastasis than in those with extrahepatic metastasis(P = 0.025). Patients with grade A and B liver function reserve had higher AIM2 mRNA expression levels than patients with grade C (P < 0.001). Conclusion The expression level of AIM2 mRNA in PBMCs is negatively associated with the progression of HCC. AIM2 is a potential biomarker for the prognostic evaluation of HCC and a potential target for therapeutic intervention.

Key words: Absent in melanoma 2, Primary hepatocellular carcinoma, Peripheral blood mononuclear cells

陈洪涛, 杨智, 吴诗品. 外周血单个核细胞黑色素瘤缺乏因子2在原发性肝癌中的表达及其临床意义[J]. 新发传染病电子杂志, 2019, 4(3): 149-151.

CHEN Hong-tao, Yang Zhi, WU Shi-pin. Expression of absent in melanoma 2 mRNA in peripheral blood mononuclears and its significance in primary hepatocellular carcinoma[J]. Electronic Journal of Emerging Infectious Diseases, 2019, 4(3): 149-151.

参考文献

[1] 陈洪涛, 陈月, 吴诗品. NLRP3、AIM2、IFI16炎症小体在慢性乙型病毒性肝炎患者PBMC中的活化水平和与HBV感染的相关性分析[J]. 暨南大学学报(自然科学与医学版), 2017, 38(4):322-329.
[2] Chen HT, He GR, Chen Y, et al.Differential Activation of NLRP3, AIM2, and IFI16 Inflammasomes in Humans with Acute and Chronic Hepatitis B[J]. Viral Immunol, 2018, 31(9):1-7.
[3] Chen SL, Liu LL, Lu SX, et al.HBx-mediated decrease of AIM2 contributes to hepatocellular carcinoma metastasis[J]. Mol Oncol, 2017, 11(9):1225-1240.
[4] Ma X, Guo P, Qiu Y, et al.Loss of AIM2 expression promotes hepatocarcinoma progression through activation of mTOR-S6K1 pathway[J]. Oncotarget, 2016, 7(24):36185-36197.
[5] Hornung V, Ablasser A, Charrel-Dennis M, et al.AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC[J]. Nature, 2009, 458(7237):514-518.
[6] Coffelt SB, De Visser K E. Cancer: Inflammation lights the way to metastasis[J]. Nature, 2014, 507(7490):48-49.
[7] Choubey D.Absent in melanoma 2 proteins in the development of cancer[J].Cell Mol Life Sci, 2016, 73(23):4383-4395
[8] Chai D, Shan H, Wang G, et al.AIM2 is a potential therapeutic target in human renal carcinoma and suppresses its invasion and metastasis via enhancing autophagy induction[J]. Exp Cell Res, 2018, 370(2):561-570.
[9] Zhang Z, Dong X, Yang X, et al.Expression and clinical significance of absent in melanoma 2 in colorectal cancer[J].Biomed Pharmacother, 2017, 94:843-849.
[10] Chen J, Wang Z, Yu S.AIM2 regulates viability and apoptosis in human colorectal cancer cells via the PI3K/Akt pathway[J]. Onco Targets Ther, 2017, 13(10):811-817.
[11] He L, Chen Y, Wu Y, et al.Nucleic acid sensing pattern recognition receptors in the development of colorectal cancer and colitis[J]. Cell Mol Life Sci, 2017, 74(13):2395-2411.
[12] Karki R, Man SM, Kanneganti TD.Inflammasomes and Cancer[J]. Cancer Immunol Res, 2017, 5(2):94-99.